Neurology® Podcast Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
Apr 8, 2024
Dr. Elizabeth Gerstner discusses the use of CAR-T cells in treating glioblastoma, targeting specific genetic markers like EGFR-V3. She explains the challenges of recurrence, outcomes, and potential impact on improving treatment efficacy by targeting the tumor microenvironment. The podcast addresses the limited eligibility and need for further research before broader implementation in patient care.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 4min
Innovative CAR-T Cell Treatment Protocol for Glioblastoma
03:48 • 3min
Outcomes and Monitoring Responses in Recurrent Glioblastoma Patients Treated with CAR T-Cell Therapy
06:52 • 5min
Advancing CAR-T Cell Therapy for Glioblastoma: Targeting Specific Genetic Markers
11:45 • 4min
Promising but Limited Impact of T-Cell Therapy on Recurrent Glioblastoma Patients
15:34 • 2min